PAPER Kashima Y, Miyazawa M
SEARCH RESULTS
331007 RESULTS
PAPER Abuhassan K, Coyle D, Belatreche A, Maguire L
Compensating for synaptic loss in Alzheimer's disease.
J Comput Neurosci. 2013 Jun 2; PubMed: 23728490PAPER Birks J, McGuinness B, Craig D
Rivastigmine for vascular cognitive impairment.
Cochrane Database Syst Rev. 2013;5:CD004744. PubMed: 23728651PAPER Richter M, Hoffmann R, Singer D
T-cell epitope-dependent immune response in inbred (C57BL/6J, SJL/J, and C3H/HeN) and transgenic P301S and Tg2576 mice.
J Pept Sci. 2013 Jul;19(7):441-51. PubMed: 23728915PAPER Tan Y, Ji YB, Zhao J
[Research progress of transgenic drosophila model of Alzheimer disease].
Yao Xue Xue Bao. 2013 Mar;48(3):333-6. PubMed: 23724643PAPER Gómez-Tortosa E, Guerrero-López R, Gil-Neciga E, Franco E, del Ser T, Jiménez Escrig A, Pérez-Pérez J, Sainz MJ
Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy.
Eur J Neurol. 2013 Sep;20(9):1319-24. PubMed: 23724906PAPER Handels RL, Wolfs CA, Aalten P, Joore MA, Verhey FR, Severens JL
Diagnosing Alzheimer's disease: A systematic review of economic evaluations.
Alzheimers Dement. 2013 May 30; PubMed: 23727080PAPER Carney RM, Kohli MA, Kunkle BW, Naj AC, Gilbert JR, Züchner S, Pericak-Vance MA
Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation.
Alzheimers Dement. 2013 May 30; PubMed: 23727082PAPER Henderson VW
Alzheimer's disease: Review of hormone therapy trials and implications for treatment and prevention after menopause.
J Steroid Biochem Mol Biol. 2013 May 28; PubMed: 23727128Ross Macdonald
NoneHouston, United States
MAPT P301T
MUTATIONS MAPT 44087754 GRCh37/hg19 rs63751438 C A g.123789C> A g.120968C> A Exon 10 Point, Missense Coding Unknown. Globular deposits composed of four-repeat tau in astrocytes and oligodendrocytes, characteristic of globular glial tauopathy. Neuron loss in f
MAPT N296del
MUTATIONS MAPT 44087739 GRCh37/hg19 rs63751392 AAT--- ΔN296 N296del Exon 10 Deletion Coding The N296del mutation has little or no effect on exon 10 splicing, but substantially reduces tau's ability to promote microtubule assembly and increases its aggregation
MAPT N296H
MUTATIONS MAPT 44087739 GRCh37/hg19 rs63750416 A C Exon 10 Point, Missense Coding This mutation increases the inclusion of exon 10 in tau mRNA and therefore increases the ratio of 4R/3R tau. It reduces tau's ability to promote tubulin polymerization and microt
PAPER Wang IM, Zhang B, Yang X, Zhu J, Stepaniants S, Zhang C, Meng Q, Peters M, He Y, Ni C, Slipetz D, Crackower MA, Houshyar H, Tan CM, Asante-Appiah E, O'Neill G, Luo MJ, Thieringer R, Yuan J, Chiu CS, Lum PY, Lamb J, Boie Y, Wilkinson HA, Schadt EE, Dai H, Roberts C
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers.
Mol Syst Biol. 2012;8:594. PubMed: 22806142MAPT N296N
MUTATIONS MAPT 44087741 GRCh37/hg19 rs63750912 T C Exon 10 Point, Silent Coding Increased inclusion of exon 10 in tau mRNA and thus increased the ratio of 4R/3R tau protein. Frontotemporal atrophy; Neuronal loss in the globus pallidus, substantia nigra, and locus c
Current Filters
No filters selected